A comparative 90-day toxicity study of allyl acetate, allyl alcohol and acrolein

Toxicology

Volumn 253, Issue 1-3, 2008, Pages 79-88

  Auerbach, Scott S ^a   Mahler, Joel ^a   Travlos, Gregory S ^a   Irwin, Richard D ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Acrolein; Allyl acetate; Allyl alcohol; Gavage; Prechronic

Indexed keywords

ACETIC ACID; ACETYLCYSTEINE; ACROLEIN; ALLYL ALCOHOL; METHYLCELLULOSE;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING; CELL DEATH; CELL HYPERPLASIA; CONTROLLED STUDY; FEMALE; FORESTOMACH; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH HEMORRHAGE;

ACETATES; ACETYLCYSTEINE; ACROLEIN; ALLYL COMPOUNDS; ANIMALS; BLOOD CELL COUNT; FEMALE; GASTRIC MUCOSA; HEMATOPOIETIC SYSTEM; LIVER; LYMPHOID TISSUE; MALE; MICE; PROPANOLS; RATS; RATS, INBRED F344; STOMACH; SURVIVAL RATE; TOXICITY TESTS;

ANIMALIA; MUS; RATTUS;

EID: 55049105994     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.08.014     Document Type: Article

References (44)

1. Allen D.G., Pearse G., Haseman J.K., and Maronpot R.R. Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies. Toxicol. Pathol. 32 (2004) 393-401
2. Badr M.Z. Effects of the anti-AIDS drug dideoxyinosine on hepatic glycolysis in the perfused rat liver: role of intracellular calcium stores. Biochem. Pharmacol. 41 (1991) 146-148
3. Barros A.R., Sierra L.M., and Comendador M.A. Acrolein genotoxicity in Drosophila melanogaster. III. Effects of metabolism modification. Mut. Res./Genet. Toxicol. 321 (1994) 119-126
4. Bedard L.L., Alessi M., Davey S., and Massey T.E. Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat. Cancer Res. 65 (2005) 1265-1270
5. Belinsky S.A., Bradford B.U., Forman D.T., Glassman E.B., Felder M.R., and Thurman R.G. Hepatotoxicity due to allyl alcohol in deermice depends on alcohol dehydrogenase. Hepatology 5 (1985) 1179-1182
6. Besaratinia A., and Pfeifer G.P. Genotoxicity of acrylamide and glycidamide. J. Natl. Cancer Inst. 96 (2004) 1023-1029
7. Butterworth K.R., Carpanini F.M., Gaunt I.F., Grasso P., and Lloyd A.G. Proceedings: a new approach to the evaluation of the safety of flavouring esters. British journal of pharmacology 54 (1975) 268P
8. Carlson R.M. Assessment of the propensity for covalent binding of electrophiles to biological substrates. Environ. Health Perspect. 87 (1990) 227-232
9. Cohen S.M., Garland E.M., St John M., Okamura T., and Smith R.A. Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res. 52 (1992) 3577-3581
10. Crabb D.W., Matsumoto M., Chang D., and You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc. Nutr. Soc. 63 (2004) 49-63
11. Dean B.J., Brooks T.M., Hodson-Walker G., and Hutson D.H. Genetic toxicology testing of 41 industrial chemicals. Mutat. Res. 153 (1985) 57-77
12. Dunn O.J. Multiple comparisons using rank sums. Technometrics 6 (1964) 241-252
13. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50 (1955) 1096-1121
14. Feng Z., Hu W., Hu Y., and Tang M.S. Acrolein is a major cigarette-related lung cancer agent: preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 15404-15409
15. Feron V.J., Til H.P., de Vrijer F., Woutersen R.A., Cassee F.R., and van Bladeren P.J. Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 259 (1991) 363-385
16. Foiles P.G., Akerkar S.A., and Chung F.L. Application of an immunoassay for cyclic acrolein deoxyguanosine adducts to assess their formation in DNA of Salmonella typhimurium under conditions of mutation induction by acrolein. Carcinogenesis 10 (1989) 87-90
17. Gart J.J., Chu K.C., and Tarone R.E. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. J. Natl. Cancer Inst. 62 (1979) 957-974
18. Ghilarducci D.P., and Tjeerdema R.S. Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144 (1995) 95-146
19. Gysin R., Kraftsik R., Sandell J., Bovet P., Chappuis C., et al. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 16621-16626
20. Imai T. Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug Metab. Pharmacokinet. 21 (2006) 173-185
21. Irwin, R.D., 2006. NTP technical report on the comparative toxicity studies of allyl acetate (CAS no. 591-87-7), allyl alcohol (CAS no. 107-18-6) and acrolein (CAS no. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice. Toxicity report series, pp. 1-73, A1-H10.
22. Kaye C.M. Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein. Biochem. J. 134 (1973) 1093-1101
23. Kehrer J.P., and Biswal S.S. The molecular effects of acrolein. Toxicol. Sci. 57 (2000) 6-15
24. Liao H.-P., Smith Jr., L.A., Tuemmler, W.B. Conversion of allyl alcohol to glycerol. US Patent number 3454655, 1969. United States.
25. Lijinsky W., and Reuber M.D. Chronic carcinogenesis studies of acrolein and related compounds. Toxicol. Ind. Health 3 (1987) 337-345
26. Marsh S., Xiao M., Yu J., Ahluwalia R., Minton M., et al. Pharmacogenomic assessment of carboxylesterases 1 and 2. Genomics 84 (2004) 661-668
27. Nakamura S., Kugiyama K., Sugiyama S., Miyamoto S., Koide S., et al. Polymorphism in the 5′-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 105 (2002) 2968-2973
28. NTP, 1983. Carcinogenesis Studies of Allyl Isovalerate (CAS no. 2835-39-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies). In: Natl Toxicol Program Tech Rep Ser, pp. 1-185.
29. Parent R.A., Caravello H.E., and Long J.E. Oncogenicity study of acrolein in mice. J. Am. Coll. Toxicol. 10 (1991) 647-659
30. Parent R.A., Caravello H.E., and Long J.E. Two-year toxicity and carcinogenicity study of acrolein in rats. J. Appl. Toxicol. 12 (1992) 131-139
31. Parent R.A., Caravello H.E., and Sharp D.E. Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. J. Appl. Toxicol. 16 (1996) 449-457
32. Reid W.D. Mechanism of allyl alcohol-induced hepatic necrosis. Experientia 28 (1972) 1058-1061
33. Rikans L.E. The oxidation of acrolein by rat liver aldehyde dehydrogenases. Relation to allyl alcohol hepatotoxicity. Drug Metab. Dispos. 15 (1987) 356-362
34. Rikans L.E., and Moore D.R. Effect of age and sex on allyl alcohol hepatotoxicity in rats: role of liver alcohol and aldehyde dehydrogenase activities. J. Pharmacol. Exp. Ther. 243 (1987) 20-26
35. Sanduja R., Ansari G.A., and Boor P.J. 3-Hydroxypropylmercapturic acid: a biologic marker of exposure to allylic and related compounds. J. Appl. Toxicol. 9 (1989) 235-238
36. Scorecard, 2005. Chemical Profile for allyl alcohol Green Media Toolshed.
37. Shirley E. A non-parametric equivalent of Williams' test for contrasting increasing dose levels of a treatment. Biometrics 33 (1977) 386-389
38. Silver E.H., and Murphy S.D. Effect of carboxylesterase inhibitors on the acute hepatotoxicity of esters of allyl alcohol. Toxicol. Appl. Pharmacol. 45 (1978) 377-389
39. Smith R.A., Cohen S.M., and Lawson T.A. Acrolein mutagenicity in the V79 assay. Carcinogenesis 11 (1990) 497-498
40. Tosic M., Ott J., Barral S., Bovet P., Deppen P., et al. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am. J. Hum. Genet. 79 (2006) 586-592
41. WHO, 1997. Evaluation of certain food additives and contaminants. Forty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organ Tech Rep Ser 868:i-viii, 1-69.
42. Williams D.A. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27 (1971) 103-117
43. Williams D.A. The comparison of several dose levels with a zero dose control. Biometrics 28 (1972) 519-531
44. Wilson V.L., Foiles P.G., Chung F.L., Povey A.C., Frank A.A., and Harris C.C. Detection of acrolein and crotonaldehyde DNA adducts in cultured human cells and canine peripheral blood lymphocytes by 32P-postlabeling and nucleotide chromatography. Carcinogenesis 12 (1991) 1483-1490